Soft Tissue Repair Market: Product launches and patent approval by key players to boost market

Transparency Market Research has published a new report titled, “Soft Tissue Repair Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”.

Transparency Market Research (TMR) has published a new report titled, “Soft Tissue Repair Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”. According to the report, the global soft tissue repair market is anticipated expand at a CAGR of 6.3% from 2018 to 2026. High prevalence of sports and orthopedic injuries and increase prevalence of breast reconstruction and hernia repair are projected to augment the global market between 2018 and 2026.

Rise in prevalence of breast reconstruction and hernia repair to propel the market

Increase in number of prevalence of breast reconstruction is driving the soft tissue repair market. The market Asia Pacific is expected to expand at a significant pace during the forecast period owing to the increase number of surgical procedures, such as hernia repair, rise in number of product offerings in China and Australia, and rapid development of the medical device industry.

Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=14687

Increase in prevalence of sports and orthopedic injuries

Increase in participation in sports and physical fitness activities are propelling the market for soft tissue repair. Rise in prevalence of sports injuries, increase in number of orthopedic procedures, and increase in geriatric population in emerging economics, such as China, India, and Australia, are anticipated to fuel the market in Asia Pacific.

Available alternatives for soft tissue repair

Available alternatives for soft tissue repair restrains the soft tissue repair market. Alternative therapies, such as physiotherapy, orthopedic manual therapy, PRICE, i.e., protection, rest, ice, compression, and elevation, are hampering the market for soft tissue repair. Apart from this, painkiller such as non-steroidal anti-inflammatory drugs used to ease pain and reduce any swelling of acute soft tissue injuries. Additionally, corticosteroids injections can also be recommended for persistent inflammation, which ultimately restrains the market for soft tissue repair.

Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=14687

Technological advancements offer future opportunity

Technological advancements are projected to increase during the forecast period. ARTELON DYNAMIC MATRIX, a product of Artelon, has advantage over the suture and tissue graft. It maintains the natural stiffness and enhances the strength. Additionally, it provides a broad elastic profile, which promotes reproducible surgical tensioning. CelGro, a product of Orthocell, is a highly effective scaffold medical device. CelGro has the capability to enhance tissue growth and repair injuries.

Request for Analysis of the COVID19 Impact on Soft Tissue Repair Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=14687

Product launches and patent approval by key players to boost market

The report also provides profiles of leading players operating in the global soft tissue repair market. These include American Medical Systems Inc (Boston Scientific), Arthrex, Inc., C.R. Bard, Inc., Covidien plc (Medtornic), Depuy Synthesis (Johnson & Johnson), Integra LifeScience Corporation, LifeCell Corporation (Allergan), Smith & Nephew, Stryker, and Wright Medical Group N.V. New product launches and focus on developing technologically advanced product and patent approval are expected to drive the global market during the forecast period. In November 2017, Orthocell Limited received approval from European regulatory for its CelGro collagen medical devices that are utilized for dental bone and soft tissue regeneration procedures. In January 2016, AlloSource, provider of cartilage, cellular, bone, skin and soft-tissue allografts for use in surgical procedures and wound care, received U.S. patent for its new cartilage repair allograft, ProChondrix Cartilage Restoration Matrix.

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

Contact

Transparency Market Research
State Tower,
90 State Street,
Suite 700
Albany NY - 12207United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com